Viewing Study NCT01772212


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2026-03-18 @ 11:21 PM
Study NCT ID: NCT01772212
Status: COMPLETED
Last Update Posted: 2017-06-22
First Post: 2013-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study for Terbinafine 250 mg
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mycoses View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mexico View
None terbinafine View
None mycoses View
None pharmacokinetics View